Diabetes
Pharmaceutical Corporations Eli Lilly, Novo Nordisk, and Sanofi Must Make Insulin Pens Available at $1 Per Pen
Press Release - 11 Nov 2024
HIV/Aids
MSF Prepares to Launch an Innovative Long-Acting HIV Prevention Program in Several African Countries
Latest News - 11 Nov 2024
Access to Healthcare
Migrating while managing diabetes, why access to insulin in pens must be available to everyone
Latest News - 6 Nov 2024
Armed conflict